RoosterBio Products Continue to Support hMSC-Related Peer-Reviewed Publications in a Growing Number of… July 13, 2020 Corporate, Tissue Engineering
RoosterBio Supports ISCT and ISEV Position Statement on Outlining Promise and Caution of hMSC… June 05, 2020 Corporate, COVID-19, EVs & Exosomes
MSCs as Medical Stockpiled Countermeasures: Cellular “First Responders” for COVID-19 and… May 20, 2020 Biomanufacturing, Cell Therapy, COVID-19
Productivity Metric Considerations in MSC & MSC-EV Manufacturing in Response to COVID-19 May 15, 2020 Biomanufacturing, COVID-19, EVs & Exosomes
Accelerating COVID-19 Treatments with Patient Safety As First Priority April 29, 2020 Cell Therapy, COVID-19
The Race to Beat COVID-19 with hMSCs Revs Up April 24, 2020 Cell Therapy, COVID-19, MSCs & Characterization
Patience for hMSCs in COVID-19: We Must Crawl Before We Run April 14, 2020 BioEconomy, Cell Therapy, COVID-19, MSCs & Characterization
hMSCs: A Secret(ome) Weapon Against ARDS April 03, 2020 Cell Therapy, COVID-19, EVs & Exosomes, MSCs & Characterization
